As former President Donald Trump has clinched a second term with a victory, his health care priorities will differ somewhat from his first term, ...
The Times of India on MSN3d
Granules India’s Unit V facility in Andhra Pradesh gets US FDA EIR with NAI statusPharma player Granules India Limited on Friday said it has received an Establishment Inspection Report (EIR) from the US Food ...
Reuters on MSN10d
How Asian pharma suppliers cash in on Ozempic copiesJust over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro ...
India IT Services players are more insulated now from such anti-immigration policies than they were in 2016. All players have ...
seller & market expansion company for a wide range of Active Pharmaceutical Ingredients, Advanced Pharma Intermediates, ...
The Times of India on MSN2d
Aurobindo Pharma Q2 net profit rises 9%Aurobindo Pharma witnessed a nearly 9% surge in consolidated net profit for Q2FY25, reaching Rs 817 crore. This growth was fueled by an 8% rise in con ...
Granules India announced that it has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Unit V facility located at Jawaharlal Nehru Pharma ...
TORONTO, Nov. 11, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF ) (FSE: MLZ) (MediPharm, ...
It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes ...
"We don't know which countries (Semagcare is sold to) but we are doing the promotion because once they sell more, we sell more API (active pharmaceutical ingredient) to them," he told Reuters when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback